Lin Wei
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 4
- Bioinformatics and Genomic Networks 4
- Circular RNAs in diseases 3
-
- MicroRNA in disease regulation 4
- Co-authors
- Jianren Gu (8 shared papers)Yuan Ji (7 shared papers)Wenxin Qin (5 shared papers)Shengjie Yang (2 shared papers)Yitan Zhu (2 shared papers)Xianghuo He (5 shared papers)Yanxun Xu (1 shared paper)Zhilin Jin (1 shared paper)
- Journals
- Cell Death and Disease (2 papers)Hepatology (2 papers)PLoS ONE (2 papers)Scientific Reports (1 paper)Infection and Drug Resistance (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lin Wei
52 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 114
- Cancer Research 425
- Molecular Biology 766
- Hepatology 55
- Biomaterials 85
- Software 23
Countries citing papers authored by Lin Wei
This map shows the geographic impact of Lin Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Wei more than expected).
Fields of papers citing papers by Lin Wei
This network shows the impact of papers produced by Lin Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Wei. The network helps show where Lin Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 156 | |
| 2 | 2018 | 152 | |
| 3 | 2011 | 103 | |
| 4 | 2020 | 93 | |
| 5 | 2015 | 85 | |
| 6 | 2010 | 69 | |
| 7 | 2017 | 66 | |
| 8 | 2014 | 40 | |
| 9 | 2019 | 39 | |
| 10 | 2014 | 33 | |
| 11 | 2007 | 23 | |
| 12 | 2011 | 21 | |
| 13 | 2008 | 20 | |
| 14 | 2009 | 20 | |
| 15 | 2011 | 20 | |
| 16 | 2020 | 18 | |
| 17 | 2021 | 18 | |
| 18 | 2023 | 17 | |
| 19 | 2022 | 17 | |
| 20 | 2002 | 16 |
About Lin Wei
Lin Wei is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 55 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), MicroRNA in disease regulation (4 papers), Epigenetics and DNA Methylation (4 papers), Bioinformatics and Genomic Networks (4 papers), Electrospun Nanofibers in Biomedical Applications (3 papers), Software Engineering Research (3 papers), Circular RNAs in diseases (3 papers) and Bone Tissue Engineering Materials (3 papers). The work is most often cited by research in Cancer Research (425 citations), Molecular Biology (766 citations), Hepatology (55 citations), Biomaterials (85 citations) and Software (23 citations). Lin Wei has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jianren Gu, Yuan Ji, Wenxin Qin, Shengjie Yang, Yitan Zhu, Xianghuo He, Yanxun Xu, Zhilin Jin, Ming Yao and Haojie Jin. Their work appears in journals such as Cell Death and Disease, Hepatology, PLoS ONE, Scientific Reports and Infection and Drug Resistance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.